Skip to main content

Perspectives

Perspectives
A Pharmacist’s Perspective on CDK4/6 Inhibitors
Robert C. Wolf, PharmD
Read More
Perspectives
The Importance of Patient Education: A Nurse’s Perspective
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Read More
Perspectives
Increasing Focus on Value Related to Cancer Drugs: A Payer Perspective
Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Perspectives
Treatment of Advanced Breast Cancer: A Clinical Pharmacy Perspective
Val R. Adams, PharmD, FCCP, BCOP, Allison R. Butts, PharmD, BCOP
Read More
Perspectives
Pharmaceutical Patent Litigation and the Emerging Biosimilars: A Conversation with Kevin M. Nelson, JD
Stanton R. Mehr
Stanton R. Mehr
Read More
Perspectives
Employers Engaged in Benefit Design Innovation: Long-Term Trends in a 2015 National Survey
Cheryl Larson, F. Randy Vogenberg, PhD, FASHP
Read More
Perspectives
Guiding Employer Management of Specialty Drugs
Cheryl Larson, F. Randy Vogenberg, PhD, FASHP
Read More
Perspectives
Key Strategic Trends that Impact Healthcare Decision-Making and Stakeholder Roles in the New Marketplace
John Santilli, MBA, F. Randy Vogenberg, PhD, FASHP
Read More
Perspectives
Rewarding Innovation in Drug Development
Emily Saadi, Greg White, MPP
Read More
Perspectives
Population Health and the Assessment of Value
Joseph D. Jackson, PhD
Read More
Page 2 of 5
Results 11 - 20 of 48